Yuk-ki Wong

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction

Seyyare Beyzade, Shaoli Zhang, Yuk-ki Wong et al. · Journal of the American College of Cardiology · 2003 · 140 citations

Inflammation, Vascular Disease, Epidemiology +12

Chronic infection with <i>Helicobacter pylori</i>, <i>Chlamydia pneumoniae</i>, or cytomegalovirus: population based study of coronary heart disease

John Danesh, Yuk-ki Wong, Michael E. Ward et al. · Heart · 1999 · 129 citations · Full text

Circulating chlamydia pneumoniaeDNA as a predictor of coronary artery disease

Yuk-ki Wong, Keith D. Dawkins, Michael E. Ward · Journal of the American College of Cardiology · 1999 · 111 citations

Cardiovascular Disease, Chlamydia Pneumoniaedna, Public Health +3